S.2891 - Fighting the Opioid Epidemic with Sunshine Act of 2018115th Congress (2017-2018)
|Sponsor:||Sen. Grassley, Chuck [R-IA] (Introduced 05/22/2018)|
|Committees:||Senate - Finance|
|Latest Action:||Senate - 05/22/2018 Read twice and referred to the Committee on Finance. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: S.2891 — 115th Congress (2017-2018)All Information (Except Text)
Introduced in Senate (05/22/2018)
Fighting the Opioid Epidemic with Sunshine Act of 2018
This bill expands Medicaid and Medicare reporting requirements related to the transparency of physician ownership or investment interests.
Under current law, a manufacturer of drugs, devices, or medical supplies that are covered under Medicaid or Medicare must regularly report on any payment or transfer of value by the manufacturer to a “covered recipient,” defined as either a physician who is not an employee of the manufacturer or a teaching hospital. The bill expands the definition of “covered recipient” to also include any of the following practitioners who is not an employee of the manufacturer: (1) a physician assistant, (2) a nurse practitioner, (3) a clinical nurse specialist, (4) a certified registered nurse anesthetist, or (5) a certified nurse-midwife.